← The Wire
EIKNNasdaq
Eikon Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1861123
Eikon Therapeutics develops important medicines for serious unmet medical needs using proprietary technology
red 8-K · 90d
$474M
Market cap
$12.74
Last close
+11.3%
1D
+32.4%
5D
461K
Volume
Price · last 39 sessions+24.1%
May 4L $8.36 · H $13.25Jun 29
10
Total filings
Jun 10, 2026
Last filing
12/31
Fiscal year end
8-KExecutive ChangeJun 10, 20268-KReg FD Disclosure · Company UpdateJun 1, 202610-Q10-QMay 11, 20268-KResults of Operations · Reg FD DisclosureMay 11, 20268-KResults of OperationsMar 30, 202610-K10-KMar 30, 2026SC 13DSC 13DFeb 12, 20268-KBylaw AmendmentFeb 6, 2026424B4424B4Feb 5, 2026S-1/AS-1/AJan 28, 2026S-1S-1Jan 9, 2026
Insider Activity
◆ Cluster Buy · 5 insidersIn the 90 days to Feb 6, 2026: 5 insiders bought $46.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 6, 2026 | Column Group Opportunity Iii, LpTenPercentOwner | Buy | 1,437,323 | $18.00 | $25.9M |
| Feb 6, 2026 | Column Group Opportunity Iii, LpTenPercentOwner | Buy | 630,881 | $18.00 | $11.4M |
| Feb 6, 2026 | Column Group Opportunity Iii, LpTenPercentOwner | Buy | 49,556 | $18.00 | $892K |
| Feb 4, 2026 | Lux Ventures V, L.P.TenPercentOwner | Buy | 138,888 | $18.00 | $2.5M |
| Feb 4, 2026 | Wolfe JoshDirector,TenPercentOwner | Buy | 138,888 | $18.00 | $2.5M |
| Feb 4, 2026 | Frazier Kenneth CDirector | Buy | 111,111 | $18.00 | $2.0M |
| Feb 4, 2026 | Foresite Capital Opportunity Management V, LlcTenPercentOwner | Buy | 55,555 | $18.00 | $1000K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance